The GAPS Book’s 15 to 25 Percent Antipsychotic Figure

In its schizophrenia chapter, Gut and Psychology Syndrome says antipsychotic medication can control psychotic symptoms in many cases and describes an average symptom reduction of 15 to 25 percent. The next sentence says 75 to 85 percent of symptoms remain. Reading those two statements together is essential to understanding the point Campbell-McBride is making.^[1]

The percentage concerns symptoms in her discussion, not the percentage of people helped, cured or ready to stop medication. Here is how to read it without losing either the symptom control she acknowledges or the physical-health work she wants included.

What the Figure Refers To

The paragraph concerns antipsychotic treatment for people diagnosed with schizophrenia. Campbell-McBride describes prescribing as often involving trial and error. She acknowledges control of psychotic symptoms, then calls the treatment symptomatic: in her argument, it addresses symptoms without resolving the underlying disease process.^[1]

Her 15 to 25 percent figure is part of that argument about the extent of symptom reduction. It is not a count of how many patients respond. Likewise, the remaining 75 to 85 percent describes the portion of symptoms she says remains; it does not mean that proportion of people receive no benefit at all.^[1]

Symptom Control and the Wider Physical Picture

The chapter goes on to discuss physical health: digestion, cardiovascular and metabolic problems, respiratory and urogenital infections, immune problems and poor nourishment. It uses that wider picture to explain why Campbell-McBride looks beyond psychiatric symptoms to the digestive system and nutrient status.^[1]

That is the connection between this paragraph and GAPS. She is asking what else needs attention when symptoms are partly controlled, not telling a reader to discard the control a medicine provides. The complete schizophrenia guide follows the chapter’s nutrition, history and research sections without repeating them all here.

Keep Three Different Questions Separate

• What does the book say? It reports an average symptom-reduction figure within the schizophrenia discussion.
• What has happened for this person? That requires the actual treatment history: symptoms, daily functioning, effects and unwanted effects.
• Should the prescription change? That is a separate decision with the prescribing psychiatrist; the percentage is not a dose-adjustment rule.

An average in a book cannot tell you how much of one person’s improvement comes from a medicine or predict what happens if it changes. For your own record, concrete examples are more useful than trying to score yourself against that range. Write down which symptom changed, when it changed and what became easier or harder in daily life.

How the Medication Passage Fits

Later in the same chapter, Campbell-McBride says existing medication should remain unchanged during the initial nutritional work. She considers a later reduction only after physical and mental improvement is substantial and stable, with the psychiatrist closely involved in a very slow, step-by-step process. She warns that abrupt withdrawal can cause a severe reaction that may be mistaken for relapse.^[2]

Those instructions matter when reading her criticism of medication. The book’s symptom figure does not cancel its medication sequence. My antipsychotic tapering and withdrawal guide explains the complete passage, including the distinct diet and stability conditions.

Your Next Step

If you came here because the percentage worried you, take the whole question to your next appointment: which symptoms are controlled, which remain, and what physical or digestive problems also need attention? Keep your current treatment record beside that conversation.

The Care Team Log in my WFLI Shop is intended to organize those dates and questions. You can start now with a notebook page headed “What Changed, What Remains, and What I Want to Ask.” For the wider gut explanation, continue with GAPS and psychiatry.

References

1. Campbell-McBride, Natasha. Gut and Psychology Syndrome, expanded text represented by the second German edition (2015). English paraphrases checked against that edition; no English-edition page numbers are implied. “Schizophrenie,” opening medication paragraph and following physical-health discussion.
2. Campbell-McBride, Natasha. Gut and Psychology Syndrome, expanded text represented by the second German edition (2015). English paraphrases checked against that edition; no English-edition page numbers are implied. “Schizophrenie,” complete “Wie sieht es mit der Medikation aus?” subsection.